Clinical Trials in Arizona

Showing 4701-4720 of 16,770 trials

TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

NCT04998305

The primary objective of the study is to demonstrate the safety and potential efficacy of TJ-68 for improving muscle cramps in participants with ALS based on a two-site, randomized, placebo-controlled double-blind multi-period crossover (N-of-1) study design.

Amyotrophic Lateral SclerosisMuscle Cramp

Hiroshi Mitsumoto11 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • New York, New York, United States

Enrolling By InvitationPhase 442 miles

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

NCT05816265

Patients with heart failure with reduced ejection fraction and iron deficiency will be randomized to either receive iron infusion or be in the control group. The study is looking at how iron replacement affects exercise capacity as measured by peak oxygen uptake.

Heart FailureIron-deficiency

Radha Gopalan40 participantsStarted Jan 2024

Phoenix, Arizona, United States

Active Not RecruitingNA108 miles

Improving Sleep in Gynecologic Cancer Survivors

NCT05044975

This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.

Sleep DisturbanceGynecologic Cancer

University of Arizona95 participantsStarted Oct 2021

Tucson, Arizona, United States • Chicago, Illinois, United States

TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

Improving Sleep in Gynecologic Cancer Survivors

Find Trials by Condition in Arizona

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Study of AGEN1571 in Participants With Advanced Solid Tumors

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes